Seeking Alpha

Dendreon (DNDN +1.1%) sells its immunotherapy manufacturing facility in Morris Plains, New...

Dendreon (DNDN +1.1%) sells its immunotherapy manufacturing facility in Morris Plains, New Jersey, to Novartis (NVS) for $43M in cash. The sale is part of Dendreon's restructuring plans on "its path to profitability and future growth." The plant was used to manufacture cancer drug Provenge, which has had its marketing troubles.
Comments (1)
  • vtstuart
    , contributor
    Comments (122) | Send Message
     
    Lower expenses, plus cash - a step in the right direction.
    20 Dec 2012, 10:13 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector